OPS
CBAY

Orion Portfolio Solutions’s Cymabay Therapeutics CBAY Stock Holding History

Orion Portfolio Solutions’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,357
Closed -$291K – 1765
2023
Q4 		$291K Sell
12,357
-2,977
-19% -$53K ﹤0.01% 1414
2023
Q3 		$229K Buy
+15,334
New +$203K ﹤0.01% 1497

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Orion Portfolio Solutions's CBAY Position: Q1 2024 in Review

Orion Portfolio Solutions sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 12,357 shares — an estimated $291K sold.

Orion Portfolio Solutions first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $291K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Orion Portfolio Solutions reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Orion Portfolio Solutions sold 12,357 Cymabay Therapeutics shares in Q1 2024, an estimated $291K.
  • Orion Portfolio Solutions first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Orion Portfolio Solutions's Cymabay Therapeutics position peaked at $291K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Orion Portfolio Solutions's 13F filing for Q1 2024, filed 9 May 2024.